BioLineRx Ltd. ADR (NASDAQ:BLRX)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar labphm (< 20) Submitted: 2/1/2013 8:57:42 PM : Outperform Start Price: $4.13 BLRX Score: -57.37

Company to present at BIO CEO and Investor Conf. in NY on Feb. 12.
Upcoming catalyst: Company to announce interim results of Phase II/III trial during week of March 18, 2013 (schizoprenia drug)

Featured Broker Partners


Advertisement